📈 ReiThera’s method focuses on volumetric productivity using high-density cell cultures. This innovation quadruples production yield and ensures genetic stability.
⚙️ The scalable design prioritizes single-use technologies, streamlining production changes. The process could support more vaccines during health emergencies.
💉 This strategy aims for commercial production and broader applications.
Introduction:
Recent advancements in vaccine manufacturing processes have emerged, offering a potential response to health emergencies, particularly in the context of infectious disease outbreaks. ReiThera, an Italian contract development and manufacturing organization (CDMO), has developed an intensified production process that significantly enhances the efficiency and scalability of vaccine manufacturing, as demonstrated through its work on an Ebola vaccine.
- The intensified manufacturing process was initially developed for an Ebola vaccine trial in Uganda and aims to improve volumetric productivity by optimizing culture conditions.
- The process incorporates a perfusion step in a stirred tank bioreactor, resulting in a four-fold increase in production yield.
- Modifications to the HEK-293-derived packaging cell line enhance genetic stability and productivity by inserting a transcriptional repressor that stops transgene expression.
- ReiThera’s method features extensive purification processes, including depth filtration, ultrafiltration, and selective precipitation to efficiently eliminate host cell DNA.
- The manufacturing technique utilizes single-use technologies to facilitate quick transitions between different production campaigns, enabling rapid responses during health emergencies.
Conclusion:
The implementation of this new vaccine production process could significantly streamline manufacturing during health crises, leveraging its scalability and efficiency to address potential outbreaks promptly. ReiThera plans to apply this strategy to other vaccine platforms, underscoring the method’s versatility and importance in bolstering global health preparedness.
